Jan A. Nolta - Publications

Biomedical Engineering University of California, Davis, Davis, CA 
Cell Biology, Molecular Biology, Biomedical Engineering

138 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Elahi FM, Farwell DG, Nolta JA, Anderson JD. Concise Review: Preclinical Translation of Exosomes Derived from Mesenchymal Stem/Stromal Cells. Stem Cells (Dayton, Ohio). PMID 31381842 DOI: 10.1002/stem.3061  0.44
2019 Showalter MR, Wancewicz B, Fiehn O, Archard JA, Clayton S, Wagner J, Deng P, Halmai J, Fink KD, Bauer G, Fury B, Perotti NH, Apperson M, Butters J, Belafsky P, ... ... Nolta JA, et al. Primed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation. Biochemical and Biophysical Research Communications. PMID 30926165 DOI: 10.1016/j.bbrc.2019.03.119  0.44
2019 Yuan OD, Lin C, Wagner J, Archard J, Deng P, Halmai J, Bauer G, Fink K, Fury B, Perotti N, Walker J, Pollock K, Apperson M, Butters J, Belafsky P, ... ... Nolta JA, et al. Exosomes Derived from Human Primed Mesenchymal Stem Cells Induce Mitosis and Potentiate Growth Factor Secretion. Stem Cells and Development. PMID 30638129 DOI: 10.1089/scd.2018.0200  0.44
2018 Cortez-Toledo E, Rose M, Agu E, Dahlenburg H, Yao W, Nolta JA, Zhou P. Enhancing Retention of Mesenchymal Stem Cells with Pro-survival Factors Promotes Angiogenesis in a Mouse Model of Limb Ischemia. Stem Cells and Development. PMID 30398391 DOI: 10.1089/scd.2018.0090  0.4
2018 Fierro FA, Magner N, Beegle J, Dahlenburg H, Logan White J, Zhou P, Pepper K, Fury B, Coleal-Bergum DP, Bauer G, Gruenloh W, Annett G, Pifer C, Nolta JA. Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditions. Transfusion. PMID 30383901 DOI: 10.1111/trf.14914  0.44
2017 Moisseiev E, Anderson JD, Oltjen S, Goswami M, Zawadzki RJ, Nolta JA, Park SS. Protective Effect of Intravitreal Administration of Exosomes Derived from Mesenchymal Stem Cells on Retinal Ischemia. Current Eye Research. 1-10. PMID 28636406 DOI: 10.1080/02713683.2017.1319491  0.44
2017 Kuhn MA, Black AB, Siddiqui MT, Nolta JA, Belafsky PC. Novel murine xenograft model for the evaluation of stem cell therapy for profound dysphagia. The Laryngoscope. PMID 28543406 DOI: 10.1002/lary.26666  0.44
2016 Park SS, Moisseiev E, Bauer G, Anderson JD, Grant MB, Zam A, Zawadzki RJ, Werner JS, Nolta JA. Advances in bone marrow stem cell therapy for retinal dysfunction. Progress in Retinal and Eye Research. PMID 27784628 DOI: 10.1016/j.preteyeres.2016.10.002  0.44
2016 Beegle JR, Magner NL, Kalomoiris S, Harding A, Zhou P, Nacey C, White JL, Pepper K, Gruenloh W, Annett G, Nolta JA, Fierro FA. Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia. Molecular Therapy. Methods & Clinical Development. 3: 16053. PMID 27610394 DOI: 10.1038/mtm.2016.53  0.44
2016 Moisseiev E, Smit-McBride Z, Oltjen S, Zhang P, Zawadzki RJ, Motta M, Murphy CJ, Cary W, Annett G, Nolta JA, Park SS. Intravitreal Administration of Human Bone Marrow CD34+ Stem Cells in a Murine Model of Retinal Degeneration. Investigative Ophthalmology & Visual Science. 57: 4125-4135. PMID 27537262 DOI: 10.1167/iovs.16-19252  0.44
2016 Deng P, Torrest A, Pollock K, Dahlenburg H, Annett G, Nolta JA, Fink KD. Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells. Neural Regeneration Research. 11: 702-5. PMID 27335539 DOI: 10.4103/1673-5374.182682  0.44
2016 Deng P, Anderson JD, Yu AS, Annett G, Fink KD, Nolta JA. Engineered BDNF producing cells as a potential treatment for neurologic disease. Expert Opinion On Biological Therapy. PMID 27159050 DOI: 10.1080/14712598.2016.1183641  0.44
2016 Fink KD, Deng P, Gutierrez J, Anderson JS, Torrest A, Komarla A, Kalomoiris S, Cary W, Anderson JD, Gruenloh W, Duffy A, Tempkin T, Wheelock V, Segal DJ, Nolta JA. Allele-specific reduction of the mutant huntingtin allele using transcription activator-like effectors in human Huntington's disease fibroblasts. Cell Transplantation. PMID 26850319 DOI: 10.3727/096368916X690863  0.44
2016 Anderson JD, Johansson HJ, Graham CS, Vesterlund M, Pham MT, Bramlett CS, Montgomery EN, Mellema MS, Bardini RL, Bauer G, Fink KD, Fury B, Hendrix KJ, Chedin F, El-Andaloussi S, ... ... Nolta JA, et al. Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via NFkB Signaling. Stem Cells (Dayton, Ohio). PMID 26782178 DOI: 10.1002/stem.2298  0.44
2016 Pollock K, Dahlenburg H, Nelson H, Fink KD, Cary W, Hendrix K, Annett G, Torrest A, Deng P, Gutierrez J, Nacey C, Pepper K, Kalomoiris S, Anderson JD, McGee JL, ... ... Nolta JA, et al. Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's disease Mouse Models. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26765769 DOI: 10.1038/mt.2016.12  0.44
2016 Lakatos K, Kalomoiris S, Merkely B, Nolta JA, Fierro FA. Mesenchymal Stem Cells Respond to Hypoxia by Increasing Diacylglycerols. Journal of Cellular Biochemistry. 117: 300-7. PMID 26212931 DOI: 10.1002/jcb.25292  0.44
2016 Deng P, Torrest A, Pollock K, Dahlenburg H, Annett G, Nolta JA, Fink KD. Clinical trial perspective for adult and juvenile Huntington’s disease using genetically-engineered mesenchymal stem cells Neural Regeneration Research. 11: 702-705. DOI: 10.4103/1673-5374.182682  0.44
2016 Nolta JA. "next-generation" mesenchymal stem or stromal cells for the in vivo delivery of bioactive factors: Progressing toward the clinic Transfusion. 56: 15S-17S. DOI: 10.1111/trf.13564  0.44
2016 Kalomoiris S, Cicchetto AC, Lakatos K, Nolta JA, Fierro FA. Fibroblast Growth Factor 2 Regulates High Mobility Group A2 Expression in Human Bone Marrow-Derived Mesenchymal Stem Cells Journal of Cellular Biochemistry. DOI: 10.1002/jcb.25519  0.44
2016 Jung Y, Nolta JA. BMI1 regulation of self-renewal and multipotency in human mesenchymal stem cells Current Stem Cell Research and Therapy. 11: 131-140.  0.44
2015 Black AB, Dahlenburg H, Pepper K, Nacey C, Pontow S, Kuhn MA, Belafsky PC, Nolta JA. Human Myoblast and Mesenchymal Stem Cell Interactions Visualized by Videomicroscopy. Human Gene Therapy Methods. PMID 26544924 DOI: 10.1089/hgtb.2015.100  0.32
2015 Kol A, Arzi B, Athanasiou KA, Farmer DL, Nolta JA, Rebhun RB, Chen X, Griffiths LG, Verstraete FJ, Murphy CJ, Borjesson DL. Companion animals: Translational scientist's new best friends. Science Translational Medicine. 7: 308ps21. PMID 26446953 DOI: 10.1126/scitranslmed.aaa9116  0.44
2015 McMahill BG, Spriet M, Sisó S, Manzer MD, Mitchell G, McGee J, Garcia TC, Borjesson DL, Sieber-Blum M, Nolta JA, Sturges BK. Feasibility Study of Canine Epidermal Neural Crest Stem Cell Transplantation in the Spinal Cords of Dogs. Stem Cells Translational Medicine. 4: 1173-86. PMID 26273065 DOI: 10.5966/sctm.2015-0018  0.44
2015 Vapniarsky N, Arzi B, Hu JC, Nolta JA, Athanasiou KA. Concise Review: Human Dermis as an Autologous Source of Stem Cells for Tissue Engineering and Regenerative Medicine. Stem Cells Translational Medicine. 4: 1187-98. PMID 26253713 DOI: 10.5966/sctm.2015-0084  0.44
2015 Fink KD, Deng P, Torrest A, Stewart H, Pollock K, Gruenloh W, Annett G, Tempkin T, Wheelock V, Nolta JA. Developing stem cell therapies for juvenile and adult-onset Huntington's disease. Regenerative Medicine. 10: 623-46. PMID 26237705 DOI: 10.2217/rme.15.25  0.44
2015 Cary WA, Hori CN, Trananh M, Nacey CA, McGee JL, Hamou M, Berman RF, Bauer G, Nolta JA, Waldau B. Efficient Generation of Induced Pluripotent Stem and Neural Progenitor Cells from Acutely Harvested Dura Mater Obtained during Ventriculoperitoneal Shunt Surgery. World Neurosurgery. PMID 26074438 DOI: 10.1016/j.wneu.2015.05.076  0.44
2015 Osborn SL, So M, Hambro S, Nolta JA, Kurzrock EA. Inosculation of blood vessels allows early perfusion and vitality of bladder grafts--implications for bioengineered bladder wall. Tissue Engineering. Part A. 21: 1906-15. PMID 25794892 DOI: 10.1089/ten.TEA.2014.0630  0.44
2015 Beegle J, Lakatos K, Kalomoiris S, Stewart H, Isseroff RR, Nolta JA, Fierro FA. Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo. Stem Cells (Dayton, Ohio). 33: 1818-28. PMID 25702874 DOI: 10.1002/stem.1976  0.44
2015 Chang AI, Schwertschkow AH, Nolta JA, Wu J. Involvement of mesenchymal stem cells in cancer progression and metastases. Current Cancer Drug Targets. 15: 88-98. PMID 25619387  0.44
2015 Barclay SL, Yang Y, Zhang S, Fong R, Barraza A, Nolta JA, Torbett BE, Abedi M, Bauer G, Anderson JS. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells. Stem Cells (Dayton, Ohio). 33: 870-9. PMID 25524029 DOI: 10.1002/stem.1919  0.44
2015 Nolta JA. New advances in understanding stem cell fate and function. Stem Cells (Dayton, Ohio). 33: 313-5. PMID 25446041 DOI: 10.1002/stem.1905  0.44
2015 McMahill BG, Borjesson DL, Sieber-Blum M, Nolta JA, Sturges BK. Stem cells in canine spinal cord injury--promise for regenerative therapy in a large animal model of human disease. Stem Cell Reviews. 11: 180-93. PMID 25173879 DOI: 10.1007/s12015-014-9553-9  0.44
2014 Gao W, Zhou P, Ma X, Tschudy-Seney B, Chen J, Magner NL, Revzin A, Nolta JA, Zern MA, Duan Y. Ethanol negatively regulates hepatic differentiation of hESC by inhibition of the MAPK/ERK signaling pathway in vitro. Plos One. 9: e112698. PMID 25393427 DOI: 10.1371/journal.pone.0112698  0.44
2014 Clark EA, Kalomoiris S, Nolta JA, Fierro FA. Concise review: MicroRNA function in multipotent mesenchymal stromal cells. Stem Cells (Dayton, Ohio). 32: 1074-82. PMID 24860868 DOI: 10.1002/stem.1623  0.44
2014 Dasu MR, Ramirez SR, La TD, Gorouhi F, Nguyen C, Lin BR, Mashburn C, Stewart H, Peavy TR, Nolta JA, Isseroff RR. Crosstalk between adrenergic and toll-like receptors in human mesenchymal stem cells and keratinocytes: a recipe for impaired wound healing. Stem Cells Translational Medicine. 3: 745-59. PMID 24760207 DOI: 10.5966/sctm.2013-0200  0.44
2014 Perez-Cunningham J, Ames E, Smith RC, Peter AK, Naidu R, Nolta JA, Murphy WJ. Natural killer cell subsets differentially reject embryonic stem cells based on licensing. Transplantation. 97: 992-8. PMID 24704665 DOI: 10.1097/TP.0000000000000063  0.44
2014 Gericota B, Anderson JS, Mitchell G, Borjesson DL, Sturges BK, Nolta JA, Sieber-Blum M. Canine epidermal neural crest stem cells: characterization and potential as therapy candidate for a large animal model of spinal cord injury. Stem Cells Translational Medicine. 3: 334-45. PMID 24443004 DOI: 10.5966/sctm.2013-0129  0.44
2014 Nolta JA. Editorial: 2013 - a year of clinical success and great scientific innovation in the stem cell field. Stem Cells (Dayton, Ohio). 32: 1-2. PMID 24375745 DOI: 10.1002/stem.1602  0.44
2014 Lee JK, Responte DJ, Cissell DD, Hu JC, Nolta JA, Athanasiou KA. Clinical translation of stem cells: insight for cartilage therapies. Critical Reviews in Biotechnology. 34: 89-100. PMID 24083452 DOI: 10.3109/07388551.2013.823596  0.44
2014 Plowman EK, Bijangi-Vishehsaraei K, Halum S, Cates D, Hanenberg H, Domer AS, Nolta JA, Belafsky PC. Autologous myoblasts attenuate atrophy and improve tongue force in a denervated tongue model: a pilot study. The Laryngoscope. 124: E20-6. PMID 23929623 DOI: 10.1002/lary.24352  0.44
2013 Binder BY, Sondergaard CS, Nolta JA, Leach JK. Lysophosphatidic acid enhances stromal cell-directed angiogenesis. Plos One. 8: e82134. PMID 24312635 DOI: 10.1371/journal.pone.0082134  0.44
2013 Magner NL, Jung Y, Wu J, Nolta JA, Zern MA, Zhou P. Insulin and IGFs enhance hepatocyte differentiation from human embryonic stem cells via the PI3K/AKT pathway. Stem Cells (Dayton, Ohio). 31: 2095-103. PMID 23836547 DOI: 10.1002/stem.1478  0.44
2013 Annett G, Bauer G, Nolta JA. Mesenchymal stem cells for trinucleotide repeat disorders. Methods in Molecular Biology (Clifton, N.J.). 1010: 79-91. PMID 23754220 DOI: 10.1007/978-1-62703-411-1_6  0.44
2013 Ma X, Duan Y, Tschudy-Seney B, Roll G, Behbahan IS, Ahuja TP, Tolstikov V, Wang C, McGee J, Khoobyari S, Nolta JA, Willenbring H, Zern MA. Highly efficient differentiation of functional hepatocytes from human induced pluripotent stem cells. Stem Cells Translational Medicine. 2: 409-19. PMID 23681950 DOI: 10.5966/sctm.2012-0160  0.44
2013 Dao MA, Nolta JA, Case CC. Immunosuppressive activity of adult marrow mesenchymal stromal cells on innate immune cells in the central nervous system Advances in Neuroimmune Biology. 4: 177-185. DOI: 10.3233/NIB-130064  0.44
2012 Kalomoiris S, Lawson J, Chen RX, Bauer G, Nolta JA, Anderson JS. CD25 preselective anti-HIV vectors for improved HIV gene therapy. Human Gene Therapy Methods. 23: 366-75. PMID 23216020 DOI: 10.1089/hgtb.2012.142  0.44
2012 Murphy WJ, Nolta JA. Autoimmune T cells lured to a FASL web of death by MSCs. Cell Stem Cell. 10: 485-7. PMID 22560070 DOI: 10.1016/j.stem.2012.04.013  0.44
2012 Walker JE, Chen RX, McGee J, Nacey C, Pollard RB, Abedi M, Bauer G, Nolta JA, Anderson JS. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector. Journal of Virology. 86: 5719-29. PMID 22398281 DOI: 10.1128/JVI.06300-11  0.44
2012 Park SS, Caballero S, Bauer G, Shibata B, Roth A, Fitzgerald PG, Forward KI, Zhou P, McGee J, Telander DG, Grant MB, Nolta JA. Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury. Investigative Ophthalmology & Visual Science. 53: 986-94. PMID 22247454 DOI: 10.1167/iovs.11-8833  0.44
2012 Olson SD, Kambal A, Pollock K, Mitchell GM, Stewart H, Kalomoiris S, Cary W, Nacey C, Pepper K, Nolta JA. Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin. Molecular and Cellular Neurosciences. 49: 271-81. PMID 22198539 DOI: 10.1016/j.mcn.2011.12.001  0.44
2012 Armstrong L, Lako M, Buckley N, Lappin TR, Murphy MJ, Nolta JA, Pittenger M, Stojkovic M. Editorial: Our top 10 developments in stem cell biology over the last 30 years. Stem Cells (Dayton, Ohio). 30: 2-9. PMID 22162299 DOI: 10.1002/stem.1007  0.44
2012 Olson SD, Pollock K, Kambal A, Cary W, Mitchell GM, Tempkin J, Stewart H, McGee J, Bauer G, Kim HS, Tempkin T, Wheelock V, Annett G, Dunbar G, Nolta JA. Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease. Molecular Neurobiology. 45: 87-98. PMID 22161544 DOI: 10.1007/s12035-011-8219-8  0.44
2012 Jung Y, Bauer G, Nolta JA. Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells (Dayton, Ohio). 30: 42-7. PMID 21898694 DOI: 10.1002/stem.727  0.44
2012 Nolta JA. Stem cells new editor Stem Cells. 30: 1. DOI: 10.1002/stem.1014  0.44
2011 Fierro FA, Kalomoiris S, Sondergaard CS, Nolta JA. Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy. Stem Cells (Dayton, Ohio). 29: 1727-37. PMID 21898687 DOI: 10.1002/stem.720  0.44
2011 Zhou P, Lessa N, Estrada DC, Severson EB, Lingala S, Zern MA, Nolta JA, Wu J. Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 17: 418-27. PMID 21445925 DOI: 10.1002/lt.22270  0.44
2011 Gruenloh W, Kambal A, Sondergaard C, McGee J, Nacey C, Kalomoiris S, Pepper K, Olson S, Fierro F, Nolta JA. Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells. Tissue Engineering. Part A. 17: 1517-25. PMID 21275830 DOI: 10.1089/ten.TEA.2010.0460  0.44
2011 Kambal A, Mitchell G, Cary W, Gruenloh W, Jung Y, Kalomoiris S, Nacey C, McGee J, Lindsey M, Fury B, Bauer G, Nolta JA, Anderson JS. Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 584-93. PMID 21119622 DOI: 10.1038/mt.2010.269  0.44
2010 Joyce N, Annett G, Wirthlin L, Olson S, Bauer G, Nolta JA. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regenerative Medicine. 5: 933-46. PMID 21082892 DOI: 10.2217/rme.10.72  0.44
2010 Meyerrose T, Olson S, Pontow S, Kalomoiris S, Jung Y, Annett G, Bauer G, Nolta JA. Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Advanced Drug Delivery Reviews. 62: 1167-74. PMID 20920540 DOI: 10.1016/j.addr.2010.09.013  0.44
2010 Stojkovic M, Pittenger MF, Nolta JA, Lako M, Lappin TR, Murphy MJ. Stem Cells' position statement on hESC research. Stem Cells (Dayton, Ohio). 28: 1A. PMID 20809560 DOI: 10.1002/stem.517  0.44
2010 Rosová I, Link D, Nolta JA. shRNA-mediated decreases in c-Met levels affect the differentiation potential of human mesenchymal stem cells and reduce their capacity for tissue repair. Tissue Engineering. Part A. 16: 2627-39. PMID 20367286 DOI: 10.1089/ten.TEA.2009.0363  0.44
2010 Sondergaard CS, Hess DA, Maxwell DJ, Weinheimer C, Rosová I, Creer MH, Piwnica-Worms D, Kovacs A, Pedersen L, Nolta JA. Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction. Journal of Translational Medicine. 8: 24. PMID 20214792 DOI: 10.1186/1479-5876-8-24  0.44
2009 Anderson JS, Javien J, Nolta JA, Bauer G. Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 2103-14. PMID 19690520 DOI: 10.1038/mt.2009.187  0.44
2009 Anderson JS, Walker J, Nolta JA, Bauer G. Specific transduction of HIV-susceptible cells for CCR5 knockdown and resistance to HIV infection: a novel method for targeted gene therapy and intracellular immunization. Journal of Acquired Immune Deficiency Syndromes (1999). 52: 152-61. PMID 19593160 DOI: 10.1097/QAI.0b013e3181b010a0  0.44
2009 Zhou P, Hohm S, Olusanya Y, Hess DA, Nolta J. Human progenitor cells with high aldehyde dehydrogenase activity efficiently engraft into damaged liver in a novel model. Hepatology (Baltimore, Md.). 49: 1992-2000. PMID 19437487 DOI: 10.1002/hep.22862  0.44
2009 Capoccia BJ, Robson DL, Levac KD, Maxwell DJ, Hohm SA, Neelamkavil MJ, Bell GI, Xenocostas A, Link DC, Piwnica-Worms D, Nolta JA, Hess DA. Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity. Blood. 113: 5340-51. PMID 19324906 DOI: 10.1182/blood-2008-04-154567  0.44
2008 Rosová I, Dao M, Capoccia B, Link D, Nolta JA. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells (Dayton, Ohio). 26: 2173-82. PMID 18511601 DOI: 10.1634/stemcells.2007-1104  0.44
2008 Rich JT, Rosová I, Nolta JA, Myckatyn TM, Sandell LJ, McAlinden A. Upregulation of Runx2 and Osterix during in vitro chondrogenesis of human adipose-derived stromal cells. Biochemical and Biophysical Research Communications. 372: 230-5. PMID 18482578 DOI: 10.1016/j.bbrc.2008.05.022  0.44
2008 Bauer G, Dao MA, Case SS, Meyerrose T, Wirthlin L, Zhou P, Wang X, Herrbrich P, Arevalo J, Csik S, Skelton DC, Walker J, Pepper K, Kohn DB, Nolta JA. In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1308-15. PMID 18461052 DOI: 10.1038/mt.2008.93  0.44
2008 Meyerrose TE, Roberts M, Ohlemiller KK, Vogler CA, Wirthlin L, Nolta JA, Sands MS. Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease. Stem Cells (Dayton, Ohio). 26: 1713-22. PMID 18436861 DOI: 10.1634/stemcells.2008-0008  0.44
2008 Bonde J, Wirthlin L, Kohn DB, Nolta JA. Human hematopoietic cell culture, transduction, and analyses. Current Protocols in Human Genetics / Editorial Board, Jonathan L. Haines ... [Et Al.]. Unit 13.7. PMID 18428422 DOI: 10.1002/0471142905.hg1307s56  0.44
2008 Maxwell DJ, Bonde J, Hess DA, Hohm SA, Lahey R, Zhou P, Creer MH, Piwnica-Worms D, Nolta JA. Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells. Stem Cells (Dayton, Ohio). 26: 517-24. PMID 18055451 DOI: 10.1634/stemcells.2007-0016  0.44
2008 Hess DA, Craft TP, Wirthlin L, Hohm S, Zhou P, Eades WC, Creer MH, Sands MS, Nolta JA. Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity. Stem Cells (Dayton, Ohio). 26: 611-20. PMID 18055447 DOI: 10.1634/stemcells.2007-0429  0.44
2007 Nervi B, Rettig MP, Ritchey JK, Wang HL, Bauer G, Walker J, Bonyhadi ML, Berenson RJ, Prior JL, Piwnica-Worms D, Nolta JA, DiPersio JF. Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice. Experimental Hematology. 35: 1823-38. PMID 17764813 DOI: 10.1016/j.exphem.2007.06.007  0.44
2007 Hess DA, Bonde J, Craft TP, Craft TC, Wirthlin L, Hohm S, Lahey R, Todt LM, Dipersio JF, Devine SM, Nolta JA. Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 398-411. PMID 17382247 DOI: 10.1016/j.bbmt.2006.12.445  0.44
2007 Dao MA, Creer MH, Nolta JA, Verfaillie CM. Biology of umbilical cord blood progenitors in bone marrow niches. Blood. 110: 74-81. PMID 17371947 DOI: 10.1182/blood-2006-08-034447  0.44
2007 Partlow KC, Chen J, Brant JA, Neubauer AM, Meyerrose TE, Creer MH, Nolta JA, Caruthers SD, Lanza GM, Wickline SA. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 1647-54. PMID 17284484 DOI: 10.1096/fj.06-6505com  0.44
2007 Dao MA, Nolta JA. Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow. Blood. 109: 2373-9. PMID 17095623 DOI: 10.1182/blood-2006-05-026039  0.44
2007 Meyerrose TE, De Ugarte DA, Hofling AA, Herrbrich PE, Cordonnier TD, Shultz LD, Eagon JC, Wirthlin L, Sands MS, Hedrick MA, Nolta JA. In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells (Dayton, Ohio). 25: 220-7. PMID 16960135 DOI: 10.1634/stemcells.2006-0243  0.44
2007 Partlow KC, Brant JA, Marsh JN, Nolta JA, Hughes MS, Lanza GM, Wickline SA. Ultrasound energy rapidly labels stem/progenitor cells with nanoparticle beacons without disrupting membrane integrity Proceedings - Ieee Ultrasonics Symposium. 1768-1771. DOI: 10.1109/ULTSYM.2007.445  0.44
2006 Hess DA, Wirthlin L, Craft TP, Herrbrich PE, Hohm SA, Lahey R, Eades WC, Creer MH, Nolta JA. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood. 107: 2162-9. PMID 16269619 DOI: 10.1182/blood-2005-06-2284  0.44
2006 Nolta JA. Genetic engineering of mesenchymal stem cells Genetic Engineering of Mesenchymal Stem Cells. 1-169. DOI: 10.1007/1-4020-3959-X  0.44
2005 Smith E, Meyerrose TE, Kohler T, Namdar-Attar M, Bab N, Lahat O, Noh T, Li J, Karaman MW, Hacia JG, Chen TT, Nolta JA, Müller R, Bab I, Frenkel B. Leaky ribosomal scanning in mammalian genomes: significance of histone H4 alternative translation in vivo. Nucleic Acids Research. 33: 1298-308. PMID 15741183 DOI: 10.1093/nar/gki248  0.44
2005 Sohara Y, Shimada H, Minkin C, Erdreich-Epstein A, Nolta JA, DeClerck YA. Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells. Cancer Research. 65: 1129-35. PMID 15734993 DOI: 10.1158/0008-5472.CAN-04-2853  0.44
2005 Nolta JA, Jordan CT. The gold standard improves: A better assay for HSCs Blood. 106: 1141-1142. DOI: 10.1182/blood-2005-05-2064  0.44
2004 Bonde J, Hess DA, Nolta JA. Recent advances in hematopoietic stem cell biology. Current Opinion in Hematology. 11: 392-8. PMID 15548993 DOI: 10.1097/01.moh.0000145672.42503.70  0.44
2004 Hess DA, Meyerrose TE, Wirthlin L, Craft TP, Herrbrich PE, Creer MH, Nolta JA. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood. 104: 1648-55. PMID 15178579 DOI: 10.1182/blood-2004-02-0448  0.44
2003 Meyerrose TE, Herrbrich P, Hess DA, Nolta JA. Immune-deficient mouse models for analysis of human stem cells. Biotechniques. 35: 1262-72. PMID 14682062  0.44
2003 Schmidt M, Carbonaro DA, Speckmann C, Wissler M, Bohnsack J, Elder M, Aronow BJ, Nolta JA, Kohn DB, von Kalle C. Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates. Nature Medicine. 9: 463-8. PMID 12640448 DOI: 10.1038/nm844  0.44
2003 Wu GD, Nolta JA, Jin YS, Barr ML, Yu H, Starnes VA, Cramer DV. Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation. 75: 679-85. PMID 12640309 DOI: 10.1097/01.TP.0000048488.35010.95  0.44
2003 Wang X, Ge S, McNamara G, Hao QL, Crooks GM, Nolta JA. Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. Blood. 101: 4201-8. PMID 12560238 DOI: 10.1182/blood-2002-05-1338  0.44
2003 Dao MA, Arevalo J, Nolta JA. Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood. 101: 112-8. PMID 12393633 DOI: 10.1182/blood-2002-01-0025  0.44
2002 Gussoni E, Bennett RR, Muskiewicz KR, Meyerrose T, Nolta JA, Gilgoff I, Stein J, Chan YM, Lidov HG, Bönnemann CG, Von Moers A, Morris GE, Den Dunnen JT, Chamberlain JS, Kunkel LM, et al. Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. The Journal of Clinical Investigation. 110: 807-14. PMID 12235112 DOI: 10.1172/JCI16098  0.44
2002 Nolta JA, Thiemann FT, Arakawa-Hoyt J, Dao MA, Barsky LW, Moore KA, Lemischka IR, Crooks GM. The AFT024 stromal cell line supports long-term ex vivo maintenance of engrafting multipotent human hematopoietic progenitors Leukemia. 16: 352-361. PMID 11896538 DOI: 10.1038/sj/leu/2402371  0.44
2002 Dao MA, Hwa J, Nolta JA. Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+) progenitors. Blood. 99: 499-506. PMID 11781230 DOI: 10.1182/blood.V99.2.499  0.44
2002 Nolta JA. American Society of Hematology 2001 - 43rd Annual Meeting: New developments in cell-based therapies: 7-11 December 2001, Orlando, FL, USA Idrugs. 5: 8-11.  0.44
2001 Nolta JA, Jordan CT. Spotlight on hematopoietic stem cells: looking beyond dogma. Introduction. Leukemia. 15: 1677-80. PMID 11681405  0.44
2001 Wang X, Dao MA, Kuo I, Nolta JA. Phenotypic comparison of extrathymic human bone-marrow-derived T cells with thymic-selected T cells recovered from different tissues Clinical Immunology. 100: 339-348. PMID 11513547 DOI: 10.1006/clim.2001.5068  0.44
2001 Tsark EC, Dao MA, Wang X, Weinberg K, Nolta JA. IL-7 enhances the responsiveness of human T cells that develop in the bone marrow of athymic mice Journal of Immunology. 166: 170-181. PMID 11123290  0.44
2000 Evans ME, Jordan CT, Chang SM, Conrad C, Gerberding JL, Kaufman HL, Mayhall CG, Nolta JA, Pilaro AM, Sullivan S, Weber DJ, Wivel NA. Clinical infection control in gene therapy: a multidisciplinary conference. Infection Control and Hospital Epidemiology. 21: 659-73. PMID 11083185 DOI: 10.1086/501711  0.44
2000 Dao MA, Nolta JA. CD34: To select or not to select? That is the question Leukemia. 14: 773-776. PMID 10803504  0.44
2000 Arevalo JMG, Case SS, Kohn DB, Nolta JA. Effects of allogeneic support cells on human hematopoietic stem cell engraftment in a novel immune deficient mouse transplant system Blood. 96: 172a-173a.  0.44
1999 Dao MA, Tsark E, Nolta JA. Animal xenograft models for evaluation of gene transfer into human hematopoietic stem cells Current Opinion in Molecular Therapeutics. 1: 553-557. PMID 11249661  0.44
1999 Arakawa-Hoyt J, Dao MA, Thiemann F, Hao QL, Ertl DC, Weinberg KI, Crooks GM, Nolta JA. The number and generative capacity of human B lymphocyte progenitors, measured in vitro and in vivo, is higher in umbilical cord blood than in adult or pediatric bone marrow Bone Marrow Transplantation. 24: 1167-1176. PMID 10642804  0.44
1999 Dao MA, Nolta JA. Molecular control of cell cycle progression in primary human hematopoietic stem cells: Methods to increase levels of retroviral-mediated transduction Leukemia. 13: 1473-1480. PMID 10516745  0.44
1999 Dao MA, Nolta JA. Immunodeficient mice as models of human hematapoietic stem cell engraftment Current Opinion in Immunology. 11: 532-537. PMID 10508705 DOI: 10.1016/S0952-7915(99)00006-0  0.44
1999 Erdreich-Epstein A, Liu M, Kant AM, Izadi KD, Nolta JA, Durden DL. Cbl functions downstream of Src kinases in FcγRI signaling in primary human macrophages Journal of Leukocyte Biology. 65: 523-534. PMID 10204582  0.44
1998 Dunbar CE, Kohn DB, Schiffmann R, Barton NW, Nolta JA, Esplin JA, Pensiero M, Long Z, Lockey C, Emmons RV, Csik S, Leitman S, Krebs CB, Carter C, Brady RO, et al. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation. Human Gene Therapy. 9: 2629-40. PMID 9853529 DOI: 10.1089/hum.1998.9.17-2629  0.44
1998 Dao MA, Nolta JA. Use of the bnx/hu xenograft model of human hematopoiesis to optimize methods for retroviral-mediated stem cell transduction (Review) International Journal of Molecular Medicine. 1: 257-264. PMID 9852228  0.44
1998 Dao MA, Hashino K, Kato I, Nolta JA. Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells Blood. 92: 4612-4621. PMID 9845527  0.44
1998 Dao MA, Taylor N, Nolta JA. Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor β neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells Proceedings of the National Academy of Sciences of the United States of America. 95: 13006-13011. PMID 9789031 DOI: 10.1073/pnas.95.22.13006  0.44
1998 Kohn DB, Hershfield MS, Carbonaro D, Shigeoka A, Brooks J, Smogorzewska EM, Barsky LW, Chan R, Burotto F, Annett G, Nolta JA, Crooks G, Kapoor N, Elder M, Wara D, et al. T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nature Medicine. 4: 775-80. PMID 9662367 DOI: 10.1038/nm0798-775  0.44
1998 Dao MA, Shah AJ, Crooks GM, Nolta JA. Engraftment and retroviral marking of CD34+ and CD34+ CD38- human hematopoietic progenitors assessed in immune-deficient mice Blood. 91: 1243-1255. PMID 9454754  0.44
1998 Dao MA, Nolta JA. Hematopoietic stem cells as targets for human gene therapy Cancer Research Therapy and Control. 7: 19-25.  0.44
1997 Dao MA, Xiao Jin Yu, Nolta JA. Clonal diversity of primitive human hematopoietic progenitors following retroviral marking and long-term engraftment in immune-deficient mice Experimental Hematology. 25: 1357-1366. PMID 9406995  0.44
1997 Dao MA, Pepper KA, Nolta JA. Long-term cytokine production from engineered primary human stromal cells influences human hematopoiesis in an in vivo xenograft model. Stem Cells (Dayton, Ohio). 15: 443-54. PMID 9402657 DOI: 10.1002/stem.150443  0.44
1997 Dao MA, Nolta JA. Inclusion of IL-3 during retrovirally-mediated transduction on stromal support does not increase the extent of gene transfer into long-term engrafting human hematopoietic progenitors Cytokines, Cellular and Molecular Therapy. 3: 81-89. PMID 9287247  0.44
1997 Dao MA, Hannum CH, Kohn DB, Nolta JA. FLT3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral- mediated transduction Blood. 89: 446-456. PMID 9002946  0.44
1997 Dao MA, Nolta JA. Effect of tgfβ on human cd34+ progenitors on fibronectin at the cell cycle level Experimental Hematology. 25: 753.  0.44
1997 Oki MA, Nolta JA. Modulation of the extent of ritrovtral-mediated transduction of human hematopotic progenitors by antcense p271"" and amti tgfp antibody Experimental Hematology. 25: 881.  0.44
1996 Nolta JA, Dao MA, Wells S, Smogorzewska EM, Kohn DB. Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice Proceedings of the National Academy of Sciences of the United States of America. 93: 2414-2419. PMID 8637888 DOI: 10.1073/pnas.93.6.2414  0.44
1996 Dao M, Wiltshire LL, Pepper KA, Nolta JA. Human cytokine production from engineered stromal cells influences lineage development from CO-transplanted human CD 34' progenitors Experimental Hematology. 24: 1117.  0.44
1996 Pao MA, Yu XJ, Kohn DB, Nolta JA. Clonal diversity of vector-marked human henutopoietk progenitors recovered from longterm engrafted immune deficient mice Experimental Hematology. 24: 1057.  0.44
1996 Dao MA, Hashino K, Kato L, Kohn DB, Williams PA, Nolta JA. High efficiency transduction of human CD34' progenitors on fibronectin CH-296 verified by clonal integration analysis Experimental Hematology. 24: 1057.  0.44
1995 Wells S, Malik P, Pensiero M, Kohn DB, Nolta JA. The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease. Gene Therapy. 2: 512-20. PMID 8593601  0.44
1995 Nolta JA, Smogorzewska EM, Kohn DB. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells Blood. 86: 101-110. PMID 7795215  0.44
1995 Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, El-Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, et al. Engraftment of gene–modified umbilical cord blood cells in neonates with adenosine deaminase deficiency Nature Medicine. 1: 1017-1023. PMID 7489356 DOI: 10.1038/nm1095-1017  0.44
1995 Kohn DB, Krall W, Challita PM, Skelton D, Nolta JA. Gene therapy for congenital hematologic and immune disorders Bone Marrow Transplantation. 15.  0.44
1994 Hanley ME, Nolta JA, Parkman R, Kohn DB. Umbilical cord blood cell transduction by retroviral vectors: Preclinical studies to optimize gene transfer Blood Cells. 20: 539-546. PMID 7538356  0.44
1994 Nolta JA, Hanley MB, Kohn DB. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: Analysis of gene transduction of long-lived progenitors Blood. 83: 3041-3051. PMID 7514050  0.44
1992 Nolta JA, Yu XJ, Bahner I, Kohn DB. Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured gaucher bone marrow Journal of Clinical Investigation. 90: 342-348. PMID 1379609  0.44
1992 Tishler DM, Weinberg KI, Sender LS, Nolta JA, Raffel C. Multidrug resistance gene expression in pediatric primitive neuroectodermal tumors of the central nervous system Journal of Neurosurgery. 76: 507-512. PMID 1346632  0.44
1992 Nolta JA, Crooks GM, Overell RW, Williams DE, Kohn DB. Retroviral vector-mediated gene transfer into primitive human hematopoietic progenitor cells: Effects of mast cell growth factor (MGF) combined with other cytokines Experimental Hematology. 20: 1065-1071. PMID 1281784  0.44
1991 Kohn DB, Nolta JA, Weinthal J, Bahner I, Yu XJ, Lilley J, Crooks GM. Toward gene therapy for Gaucher disease. Human Gene Therapy. 2: 101-5. PMID 1911928 DOI: 10.1089/hum.1991.2.2-101  0.44
1991 Weinthal J, Nolta JA, Yu XJ, Lilley J, Uribe L, Kohn DB. Expression of human glucocerebrosidase following retroviral vector-mediated transduction of murine hematopoietic stem cells. Bone Marrow Transplantation. 8: 403-12. PMID 1768976  0.44
1990 Nolta JA, Sender LS, Barranger JA, Kohn DB. Expression of human glucocerebrosidase in murine long-term bone marrow cultures after retroviral vector-mediated transfer Blood. 75: 787-797. PMID 2297579  0.44
1990 Nolta JA, Kohn DB. Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells Human Gene Therapy. 1: 257-268. PMID 2081193  0.44
Show low-probability matches.